EUVIMEDEUVIMED entdecken
Open Access

Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3

Yan Lu, Kang Wang, Yuanhong Peng, Meng Chen, Lin Zhong, Luji Huang, F U Cheng, Xindan Sheng, Xin Yang, Manzhao Ouyang, George A Calin, Zhiwei He

Oncology Research · 2025

DOI: 10.32604/or.2024.057472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Yan Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: China-America Cancer Research Institute, Guangdong Medical University, Dongguan, 523808, China. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Tumor Microenvironment, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsTumor MicroenvironmentCell ProliferationB7 AntigensGene Expression Regulation, NeoplasticHumansFemaleCell Line, TumorApoptosisDown-Regulation

Stichwörter der Autor:innen

B7H3Breast cancerHsa-miR-214-3pImmunotherapy

Substanzen

MicroRNAsMIRN214 microRNA, humanB7 AntigensCD276 protein, human

Autor:innen und Institutionen

  • China-America Cancer Research Institute, Guangdong Medical University, Dongguan, 523808, China.
  • GCP Center, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, 528300, China.
  • Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, 528300, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510080, China.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Oncology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, 528300, China.

Zitieren

APA

Lu, Y., Wang, K., Peng, Y., Chen, M., Zhong, L., Huang, L., Cheng, F. U., Sheng, X., Yang, X., Ouyang, M., Calin, G. A., & He, Z. (2025). Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncology Research. https://doi.org/10.32604/or.2024.057472

Vancouver

Lu Y, Wang K, Peng Y, Chen M, Zhong L, Huang L, et al. Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncology Research. 2025. doi:10.32604/or.2024.057472

BibTeX
@article{Lu2025,
  author = {Lu, Yan and Wang, Kang and Peng, Yuanhong and Chen, Meng and Zhong, Lin and Huang, Luji and Cheng, F U and Sheng, Xindan and Yang, Xin and Ouyang, Manzhao and Calin, George A and He, Zhiwei},
  title = {Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.057472}
}
Kostenlos starten →